D&O Ongoing Disclosure Notice

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
Third Age Health Services Limited
Date this disclosure made:
19 December 2022
Date of last disclosure:
1 December 2022
Director or senior manager giving disclosure
Full name(s):
John Samuel Ronny Fernandes
Name of listed issuer:
Third Age Health Services Limited
Name of related body corporate (if applicable):
Position held in listed issuer:
Chairman
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
Ordinary shares
Nature of the affected relevant interest(s):
Revelant and beneficial interest
For that relevant interest-
Number held in class before acquisition or disposal:
191,168
Number held in class after acquisition or disposal:
206,168
Current registered holder(s):
(1) JSRF Limited; (2) Brian Hazelton
Walsh
Registered holder(s) once transfers are registered:
(1) JSRF Limited; (2) Brian Hazelton
Walsh
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
N/A
Class of underlying financial products:
N/A
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
N/A
A statement as to whether the derivative is cash settled or physically settled:
N/A
Maturity date of the derivative (if any):
N/A
Expiry date of the derivative(if any):
N/A
The price specified in the terms of the derivative (if any):
N/A
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
N/A
For that derivative,-
Parties to the derivative:
N/A
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:N/A
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: One (1)

Details of transactions requiring disclosure-
Date of transaction:14 December 2022
Nature of transaction:
Off-market purchase of 15,000
ordinary shares by JSRF Limited
Name of any other party or parties to the transaction (if known):XZS Holdings Limited
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value, describe the consideration:
$26,850 (being $1.79 per share)
Number of financial products to which the transaction related: 15,000
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:Yes
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
Yes
Date of the prior written clearance (if any):
6 December 2022
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:N/A
Nature of relevant interest:N/A
For that relevant interest,-
Number held in class:N/A
Current registered holder(s):N/A
For a derivative relevant interest,-
Type of derivative:
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative (if any):
The price's specified terms (if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
For that derivative relevant interest,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of director or officer:
Date of signature:19 December 2022

---

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
Third Age Health Services Limited
Date this disclosure made:
19 December 2022
Date of last disclosure:
9 December 2022
Director or senior manager giving disclosure
Full name(s):
Campbell Joseph Patterson
Name of listed issuer:
Third Age Health Services Limited
Name of related body corporate (if applicable):
N/A
Position held in listed issuer:
Senior Manager
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
Ordinary Shares
Nature of the affected relevant interest(s):
18,000 shares sold by XZS Holding
Limited (XZS) in 2 off market
transactions
For that relevant interest-
Number held in class before acquisition or disposal:
62,000
Number held in class after acquisition or disposal:
44,000
Current registered holder(s):
62,000 Ordinary Shares held by XZS
Holdings Limited in its capacity as an
asset holding company associated
with Campbell Patterson
Registered holder(s) once transfers are registered:
44,000 Ordinary Shares held by XZS
Holdings Limited in its capacity as an
asset holding company associated
with Campbell Patterson
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
N/A
Class of underlying financial products:
N/A

Ongoing Disclosure Notice
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
N/A
A statement as to whether the derivative is cash settled or physically settled:
N/A
Maturity date of the derivative (if any):
N/A
Expiry date of the derivative(if any):
N/A
The price specified in the terms of the derivative (if any):
N/A
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
N/A
For that derivative,-
Parties to the derivative:
N/A
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:N/A
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 2
Details of transactions requiring disclosure-
Date of transaction:
14 December 2022 (15,000) and 16
December 2022 (3,000)
Nature of transaction:
Off market transaction of 18,000
shares held by XZS
Name of any other party or parties to the transaction (if known):
JSRF Limited (15,000 ordinary
shares) and Tony Wai (3,000
ordinary shares)
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value, describe the consideration:
$32,220
Number of financial products to which the transaction related: 18,000 ordinary shares
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
N/A
Date of the prior written clearance (if any):
6 December 2022 and 13 December
2022
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:N/A
Nature of relevant interest:N/A
For that relevant interest,-
Number held in class:N/A
Current registered holder(s):N/A
For a derivative relevant interest,-
Type of derivative:N/A

Ongoing Disclosure Notice
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
N/A
A statement as to whether the derivative is cash settled or physically settled:N/A
Maturity date of the derivative (if any):N/A
Expiry date of the derivative (if any):N/A
The price's specified terms (if any):N/A
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
N/A
For that derivative relevant interest,-
Parties to the derivative: N/A
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
N/A
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of officer:
Date of signature: 19 December 2022

---

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
Third Age Health Services Limited
Date this disclosure made:
19 December 2022
Date of last disclosure:
21 July 2022
Director or senior manager giving disclosure
Full name(s):
Tony Andrew Wai
Name of listed issuer:
Third Age Health Services Limited
Name of related body corporate (if applicable):
N/A
Position held in listed issuer:
CEO
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
Ordinary Shares
Nature of the affected relevant interest(s):
Acquisition of 3,000 Ordinary Shares
held as registered owner
For that relevant interest-
Number held in class before acquisition or disposal:
1) 9,779 Ordinary Shares
2) 300,000 unlisted employee
options to purchase 300,000
ordinary shares
Number held in class after acquisition or disposal:
1) 12,779 Ordinary Shares
2) 300,000 unlisted employee
options to purchase 300,000
ordinary shares
Current registered holder(s):
Tony Andrew Wai
Registered holder(s) once transfers are registered:
Tony Andrew Wai
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
N/A
Class of underlying financial products:
N/A
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
N/A
A statement as to whether the derivative is cash settled or physically settled:
N/A
Maturity date of the derivative (if any):
N/A
Expiry date of the derivative(if any):
N/A
The price specified in the terms of the derivative (if any):
N/A
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
N/A
For that derivative,-
Parties to the derivative:
N/A
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:N/A
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 1

Details of transactions requiring disclosure-
Date of transaction:16 December 2022
Nature of transaction:
Off market transaction between
officers of Third Age Health Services
Limited.
Name of any other party or parties to the transaction (if known):
XZS Holdings Limited in its capacity
as an asset holding company
associated with Campbell Patterson
and Bessie Marsh, both Senior
Managers of TAH
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value, describe the consideration:
$5,370 paid in cash ($1.79 per
share)
Number of financial products to which the transaction related: 3,000 ordinary shares
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
N/A
Date of the prior written clearance (if any):
13 December 2022
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:N/A
Nature of relevant interest:N/A
For that relevant interest,-
Number held in class:N/A
Current registered holder(s):N/A
For a derivative relevant interest,-
Type of derivative:N/A
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
N/A
A statement as to whether the derivative is cash settled or physically settled:
N/A
Maturity date of the derivative (if any):
N/A
Expiry date of the derivative (if any):
N/A
The price's specified terms (if any):
N/A
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
N/A
For that derivative relevant interest,-
Parties to the derivative:
N/A
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
N/A
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of director or officer:
Date of signature:19 December 2022

---

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
Third Age Health Services Limited
Date this disclosure made:
19 December 2022
Date of last disclosure:
9 December 2022
Director or senior manager giving disclosure
Full name(s):
Bessie Marsh
Name of listed issuer:
Third Age Health Services Limited
Name of related body corporate (if applicable):
N/A
Position held in listed issuer:
Senior Manager
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
Ordinary Shares
Nature of the affected relevant interest(s):
18,000 shares sold by XZS Holding
Limited (XZS) in 2 off market
transactions
For that relevant interest-
Number held in class before acquisition or disposal:
62,250
Number held in class after acquisition or disposal:
44,250
Current registered holder(s):
1) 62,000 Ordinary Shares held by
XZS Holdings Limited in its capacity
as an asset holding company
associated with Bessie Marsh.
2) 250 shares held as registered and
beneficial owner.
Registered holder(s) once transfers are registered:
1) 44,000 Ordinary Shares held by
XZS Holdings Limited in its capacity
as an asset holding company
associated with Bessie Marsh.
2) 250 shares held as registered and
beneficial owner.
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
N/A
Class of underlying financial products:
N/A
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
N/A
A statement as to whether the derivative is cash settled or physically settled:
N/A
Maturity date of the derivative (if any):
N/A
Expiry date of the derivative(if any):
N/A
The price specified in the terms of the derivative (if any):
N/A
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
N/A
For that derivative,-
Parties to the derivative:
N/A
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
N/A

Ongoing Disclosure Notice
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 2
Details of transactions requiring disclosure-
Date of transaction:
14 December 2022 (15,000) and 16
December 2022 (3,000)
Nature of transaction:
Off market transaction of 18,000
shares held by XZS
Name of any other party or parties to the transaction (if known):
JSRF Limited (15,000 ordinary
shares) and Tony Wai (3,000
ordinary shares)
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value, describe the consideration:
$32,220
Number of financial products to which the transaction related: 18,000 ordinary shares
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
N/A
Date of the prior written clearance (if any):
6 December 2022 and 13 December
2022
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:N/A
Nature of relevant interest:N/A
For that relevant interest,-
Number held in class:N/A
Current registered holder(s):N/A
For a derivative relevant interest,-
Type of derivative:N/A
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
N/A
A statement as to whether the derivative is cash settled or physically settled:N/A
Maturity date of the derivative (if any):N/A
Expiry date of the derivative (if any):N/A
The price's specified terms (if any):N/A
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
N/A
For that derivative relevant interest,-
Parties to the derivative: N/A
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
N/A
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of officer:
Date of signature:
19 December 2022